Whereas studies on possible adverse psychiatric effects of GLP-1 ARs, like increased suicidal risk, have already been conducted and such causal relationship has not been confirmed [8], the subject of potential unfavorable impact of GLP-1 analogs on developing or persisting eating disorders has not been well documented yet. The gene discussed is GLP1R; the disease is eating disorder.